Qing-Nan Tang

18PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyPredictive and prognostic markersMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 31, 2026
Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trial.

Li-Ting Liu, Xue-Song Sun, Ting-Ting Quan

|Mar 17, 2026
A selective enrichment and specific probe terminal mediated strategy for highly sensitive detection of microRNAs.

Zecheng Zhong, Weida Huang, Jinhua Ren

|Jul 02, 2025
AK4 promotes nasopharyngeal carcinoma metastasis and chemoresistance by activating NLRP3 inflammatory complex.

Sai-Lan Liu, Li Yuan, Xue-Song Sun

|Jun 27, 2025
Anti-PD-1 antibody with or without capecitabine as maintenance therapy after first-line therapy of recurrent or metastatic nasopharyngeal carcinoma.

Yi-Fu Li, Yu Chen, Hui Cheng

|Jun 13, 2025
GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study.

Lin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang

|May 19, 2025
Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial.

Xun Cao, Zhuo-Ying Luo, Hao-Yang Huang

Pageof 3

Frequent Collaborators

6 joint publications

Linquan Tang

3 joint publications

Qiu-Yan Chen

3 joint publications

Haiqiang Mai

2 joint publications

Chong Zhao